Docstoc

AMAG Pharmaceuticals Inc to Present at Upcoming Investor Conferences

Document Sample
AMAG Pharmaceuticals Inc to Present at Upcoming Investor Conferences Powered By Docstoc
					AMAG Pharmaceuticals, Inc. to Present at
Upcoming Investor Conferences
September 12, 2011 11:26 AM Eastern Daylight Time 

LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG)
today announced that members of management will be participating in the following investor conferences:

   l   Morgan Stanley Global Healthcare Conference, September 14 at 2:10 p.m. ET in New York City
   l   UBS Global Life Sciences Conference, September 19 at 8:00 a.m. ET in New York City

A live webcast of each presentation will be accessible through the Investors section of the company’s website at
www.amagpharma.com. Following each conference, the webcast will be archived on the AMAG Pharmaceuticals,
Inc. website for approximately two weeks.

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization
of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit
www.amagpharma.com.

Contacts
AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361

Recent Stories from AMAG Pharmaceuticals, Inc.
   l   AMAG Pharmaceuticals, Inc. to Present at the Baird 2011 Healthcare Conference
       September 07, 2011
       LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ:
       AMAG) today announced that company management will participate at the Baird 2011 Healthcare
       Conference on Septembe... more »
   l   AMAG Pharmaceuticals, Inc. Board of Directors Unanimously Opposes Unsolicited Proposal from MSMB
       Capital
       August 08, 2011
       LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ:
       AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic
       iron compound... more »
   l   AMAG Pharmaceuticals, Inc. Receives Unsolicited Proposal from MSMB Capital Management
       August 03, 2011
       LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ:
       AMAG) today announced the receipt of an unsolicited proposal from MSMB Capital Management
       (“MSMB”) to acquire all ... more »

				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:7
posted:9/12/2011
language:English
pages:1
Description: LEXINGTON, Mass.--(EON: Enhanced Online News)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that members of management will be participating in the following investor conferences: Morgan Stanley Global Healthcare Conference, September 14 at 2:10 p.m. ET in New York City UBS Global Life Sciences Conference, September 19 at 8:00 a.m. ET in New York City A live webcast of each presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com. a style='font-siz
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.